Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alpha efficacy in chronic hepatitis C: don't lose the tract!

Dig Liver Dis. 2000 Aug-Sep;32(6):542-3. doi: 10.1016/s1590-8658(00)80012-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Clinical Trials as Topic
  • Cyclooxygenase Inhibitors / pharmacology*
  • Drug Interactions
  • Drug Therapy, Combination
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon-alpha / pharmacology*
  • Interferon-alpha / therapeutic use
  • Lipoxygenase Inhibitors / pharmacology*
  • Reproducibility of Results
  • Sample Size
  • Viral Load

Substances

  • Antiviral Agents
  • Cyclooxygenase Inhibitors
  • Interferon-alpha
  • Lipoxygenase Inhibitors